ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolimab + Pembro + Etoposide/Platinum vs. Atezo + EP in ES-SCLC
By
ASCO 2022 Conference Coverage
FEATURING
Jacob Sands
By
ASCO 2022 Conference Coverage
FEATURING
Jacob Sands
502 views
June 9, 2022
Login to view comments.
Click here to Login
Lung